Overview A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures. Status: Completed Trial end date: 2007-10-01 Target enrollment: Participant gender: Summary The purpose of this study is to demonstrate that RWJ-333369 is safe and effective as add-on treatment of partial onset seizures. Phase: Phase 3 Details Lead Sponsor: SK Life ScienceSK Life Science, Inc.